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CASE STUDY
Isolated third ventricle glioblastoma
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Abstract 
Introduction: Glioblastoma is the most common and the most malignant type of gliomas. Cerebral hemispheres are 
usual locations for gliomas. Isolated third ventricular presentation is very rare for glioblastomas. A new case of isolated 
third ventricular glioblastoma has been presented in this report.
Case description: A 36-year-old woman was admitted to outpatient clinic with headache, blurred vision and confu-
sion. A head CT scan and MRI had showed third ventricular mass lesion with obstructive hydrocephalus. Previous to 
her admission to our clinic, a ventriculo-peritoneal shunt had been inserted and her hydrocephalus had been relieved 
to some extent in acute settings. In our clinic, stereotactic biopsy was performed and a second ventriculoperitoneal 
shunt was inserted from the opposite site. Histopathological diagnosis was glioblastoma. Radiotherapy and chemo-
therapy were started immediately after the surgery. Patient’s hydrocephalus has resolved and she was well at post-
operative 6th month.
Discussion and evaluation: In differential diagnosis list of the tumors presenting in the third ventricle, there are 
plenty of tumors such as colloid cyst, meningioma, germinoma, craniopharyngioma, lymphoma, choroid plexus papil-
loma, subependymal giant cell astrocytoma, chiasmatic and hypothalamic benign astrocytoma. Ring enhancement 
of this region pathology is a peculiar sign for glioblastoma, yet not pathognomonic. Tumor histology is crucial to yield 
the final diagnosis.
Conclusion: Management of obstructive hydrocephalus, making histopathological diagnosis, starting adjuvant 
radiotherapy and chemotherapy in isolated third ventricular glioblastomas is a safe and effective approach when we 
consider malignant nature and intractable progress of glioblastomas.
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Introduction
Gliomas are primary tumors of central nervous system 
(CNS). They are pathologically derived from astrocytes 
(82 %), oligodendrocytes, or both cell types (Cohen and 
Colman 2015). Histologically, gliomas are graded in 4 
subtypes. Glioblastoma (grade 4 glial tumor) is the most 
common neoplasm of astrocytomas (50–60  %) (Prieto 
et al. 2006). Glial tumors mostly present in cerebral hemi-
spheres (86 %), only a very small percent of them (2.2 %) 
present in the ventricles (Larjavaara et al. 2007). Isolated 
third ventricular presentation is very rare especially for 
glioblastoma (Table 1) (Prieto et al. 2006; Lee and Man-
zano 1997; Hariri et  al. 2014; Vougiouklakis et  al. 2006; 
Lejeune et  al. 2000; Villani and Tomei 2000; Yasargil 
1996; AlbertLasierra 1999).
We present the first well-defined isolated third ven-
tricular glioblastoma, which has been managed with ste-
reotactic biopsy and adjuvant chemoradiotherapy. We 
discuss clinical, radiological, therapeutic aspects of this 
rare pathology, with a literature review.
Case report
A 36-year-old woman was admitted to outpatient clinic 
with headache, blurred vision and confusion. A head 
CT scan and MRI showed third ventricular mass lesion 
with obstructive hydrocephalus. Previous to her admis-
sion to our clinic, a ventriculo-peritoneal (V-P) shunt had 
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been inserted and her hydrocephalus had been relieved 
to some extent in acute settings. Thereafter, she had been 
referred to our clinic for management of the third ven-
tricular lesion.
In her examination, there was cognitive decline and 
gait instability. A heterogeneously enhanced multi-
cystic isolated third ventricular neoplasm was observed 
on the brain MRI (Fig.  1a–c). We also noticed that 
hydrocephalus had not completely resolved with pre-
viously inserted V-P shunt (Fig.  1d). A stereotactic 
biopsy from the mass lesion and insertion of a second 
V-P shunt from the opposite site were managed in the 
same surgical session. The surgery was successful with-
out any complication. Frozen-section result was com-
patible with high-grade glioma. Post-operative course 
of the patient was uneventful. Histopathological diag-
nosis was glioblastoma (grade 4 glioma) (Fig. 2). There 
were moderate amount of tumor cells composed of 
ovoid and round astrocyte-like cells. Mitosis activity 
was 6/10 high power fields. Vascular endothelial prolif-
eration was present with necrosis in palisading nature. 
Immunohistochemical staining depicted GFAP+, 
Olig2+, EMA−, synaptophysin−, Ki67 index of 45  %. 
Both radiotherapy and chemotherapy were conveyed 
after the final diagnosis. The patient’s general status 
was well 6  month after the biopsy, the hydrocephalus 
has resolved and the lesion has become more necrotic 
in consistency (Fig. 3).  
Discussion
Gliomas are the most common primary tumors of CNS 
in adult patients. Glioblastoma is the most malignant 
and most common type (50–60 %) of all gliomas (Prieto 
et  al. 2006). Glioblastoma incidence has been reported 
between 0.59 and 3.69 in 100,000 persons (Ostrom et al. 
2015). Usual tumor location for gliomas is cerebral hemi-
spheres. Presentation of glioblastoma solely in the third 
ventricle is very rare (Prieto et  al. 2006; Lee and Man-
zano 1997; Hariri et  al. 2014; Vougiouklakis et  al. 2006; 
Lejeune et  al. 2000; Villani and Tomei 2000; Yasargil 
1996; AlbertLasierra 1999).
Magnetic resonance imaging is useful for both diag-
nostic and therapeutic aspects. Before ascribing glio-
blastoma as pure 3rd ventricle neoplasm, its possible 
interdigitating nature with surrounding brain paren-
chyma (thalamus, caudate nucleus) should be carefully 
inspected on MRI (Prieto et  al. 2006). Third ventricu-
lar glioblastoma may have arised de novo or may have 
upgraded from a former low-grade glioma in the same 
location (Prieto et  al. 2006; Lee and Manzano 1997; 
Vougiouklakis et  al. 2006; Pasquier et  al. 2002). Origin 
for the tumors without any proof of metastasis from 
other sites (as in this case) can be subependymal glial 
tissue surrounding the third ventricle (Prieto et al. 2006; 
Lee and Manzano 1997).
In differential diagnosis list of the tumors presenting 
in the third ventricle, there are plenty of tumors such as 
colloid cyst, meningioma, germinoma, craniopharyngi-
oma, lymphoma, choroid plexus papilloma, subependy-
mal giant cell astrocytoma, chiasmatic and hypothalamic 
Fig. 1 A multi-cystic heterogeneously enhanced mass is observed in the third ventricle on T1-weighted brain MR (a–c). Temporal horns are dilated 
despite previous V-P shunt surgery (d)
Fig. 2 Histopathological appearance of the tumor (H&E ×200)
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benign astrocytoma (Lee and Manzano 1997). Ring 
enhancement is a peculiar sign for glioblastoma, yet not 
pathognomonic (Deramond et al. 2000). Tumor histology 
is crucial to yield the final diagnosis.
Total resection is possible yet hard due to very deep 
location of the tumor at the center of the brain, within 
surrounding delicate tissues and fragile vessels. Malig-
nant nature and intractable course of the tumor should 
be considered while planning treatment. Lee and Man-
zano (1997) mentioned short survival time of their patient 
after gross tumor resection. If surgical excision is still 
considered, endoscopic approach is superior to other 
approaches in respect of direct tumor visualization (Gaab 
and Schroeder 2000). Endoscopic approach to the third 
ventricle is a minimally invasive procedure compared 
to conventional craniotomy. By this approach not only 
access to the tumor itself, but also relief of the hydro-
cephalus caused by the tumor could be managed simulta-
neously using ventriculostomy, septostomy or aqueductal 
stenting (Schroeder 2013). Operative time and morbidity 
rates attributed to endoscopic approach to third ventricle 
are lower than microsurgical approach. However, com-
plete resection rate is higher in microsurgical approach 
by using two-handed techniques during the procedure 
(Ibanez-Botella et al. 2014; Sheikh et al. 2014). Reported 
complications of endoscopic approach to the 3rd ventricle 
are hemorrhage (the most common), CSF leaks, menin-
gitis, subdural hematoma, memory problems (Schroeder 
2013). Tumor size is a significant indicator for endoscopic 
approach preference. Due to eloquent nature of the 3rd 
ventricle, total resection via endoscopic approach could 
not be managed directly; instead peace-meal resection 
is preferred. Peace-meal resection could take more time 
in large-sized tumors, which might make endoscopic 
approach less favorable in this respect. Even though 
there is no one widely accepted threshold for tumor size, 
Schroeder (2013) proposed it as 2 cm. These results have 
been retrieved from large series of other kind of patholo-
gies residing purely in the 3rd ventricle. Even though it is 
impossible to make similar conclusions for 3rd ventricle 
glioblastomas since they are rare in this location (Table 1), 
it is logical to expect similar issues to be faced against. In 
the present case, the patient had already been operated 
with V-P shunt before admission to our clinic. However, 
there was recurrent hydrocephalus and the tumor was 
huge and infiltrating whole of the 3rd ventricle (Fig. 1a–c). 
Ventricular tip of the prior V-P shunt had been put into 
the right occipital horn. With the second V-P shunt, the 
third ventricle was by-passed concomitant with stereotac-
tic biopsy of the tumor. Definitive diagnosis was glioblas-
toma with Ki67 index as high as 45 %. Radiotherapy and 
chemotherapy were started immediately. The patient’s 
general status was well 6  months after the biopsy, the 
hydrocephalus has resolved and the lesion has become 
more necrotic in consistency.
Conclusion
Presentation of glioblastoma as an isolated mass in the 
third ventricle is very rare. Although MR is very useful 
in detection of the lesion, definitive diagnosis depends 
on histopathology due to many other different neoplasms 
that may present in the third ventricle. Management of 
obstructive hydrocephalus and giving radiotherapy with 
chemotherapy after histopathological diagnosis is safe 
and effective therapeutic approach in isolated third ven-
tricular glioblastoma.
Fig. 3 Post-operative 6th month brain MRI depicts resolution of hydrocephalus and more necrotic consistency of the lesion
Page 5 of 5Yılmaz et al. SpringerPlus  (2016) 5:115 
Authors’ contributions
TK managed the patient clinically, operated the patient, and supervised the 
study. BY, AA, ZOT helped the surgery and gathered the data. MSE made data 
analysis. BY, MSE, ÖY and MKD drafted the manuscript. All authors read and 
approved final manuscript.
Author details
1 Department of Neurosurgery, Medical Faculty, Bahçeşehir University, 
Istanbul, Turkey. 2 Department of Orthopedic Surgery-Spine Center, University 
of California at San Francisco, 500 Parnassus Avenue MU320 West, San 
Francisco, CA 94143-0728, USA. 3 Department of Radiology, Medical Faculty, 
Bahçeşehir University, Istanbul, Turkey. 4 Department of Pathology, Medical 
Faculty, Bahçeşehir University, Istanbul, Turkey. 
Acknowledgements
Murat Şakir Ekşi, M.D. was supported by a grant from Tubitak (The Scientific 
and Technological Research Council of Turkey), Grant No.: 1059B191400255.
Competing interests
The authors declare that they have no competing interests.
Informed consent
The patient has given her consent for the publication of her personal and 
medical information for the publication of this case report.
Received: 28 April 2015   Accepted: 28 January 2016
References
AlbertLasierra P (1999) Tumores y otros procesos de la parte anterior del III 
ventrículo. Neurocirugía 10:27–41
Cohen AL, Colman H (2015) Glioma biology and molecular markers. Cancer 
Treat Res 163:15–30. doi:10.1007/978-3-319-12048-5_2
Deramond H, Pruvo J, Gondry C, Baledent O, Desenclos C (2000) Imaging of 
tumors of the third ventricle. Neurochirurgie 46(3):239–256
Gaab M, Schroeder WS (2000) Neuroendoscopic approach to intraventricular 
tumors. In: Schmidek HH (ed) Schmidek & sweet operative neurosurgical 
techniques, indications, methods, and results, vol 1, 4th edn. Saunders, 
Philadelphia, pp 876–890
Hariri OR, Farr S, Corsino C, Bieber A, Siddiqi J (2014) Third ventricular glioblas-
toma multiforme: case report & literature review. J Neurol Surg B 75:A187
Ibanez-Botella G, Dominguez M, Ros B, De Miguel L, Marquez B, Arraez MA 
(2014) Endoscopic transchoroidal and transforaminal approaches for 
resection of third ventricular colloid cysts. Neurosurg Review 37(2):227–
234. doi:10.1007/s10143-014-0529-7 (discussion 234)
Larjavaara S, Mantyla R, Salminen T, Haapasalo H, Raitanen J, Jaaskelainen J, 
Auvinen A (2007) Incidence of gliomas by anatomic location. Neuro-
oncology 9(3):319–325. doi:10.1215/15228517-2007-016
Lee TT, Manzano GR (1997) Third ventricular glioblastoma multiforme: case 
report. Neurosurg Rev 20(4):291–294
Lejeune JP, Le Gars D, Haddad E (2000) Tumors of the third ventricle: review of 
262 cases. Neurochirurgie 46(3):211–238
Ostrom QT, Gittleman H, Stetson L, Virk SM, Barnholtz-Sloan JS 
(2015) Epidemiology of gliomas. Cancer Treat Res 163:1–14. 
doi:10.1007/978-3-319-12048-5_1
Pasquier B, Péoc’h M, Morrison AL, Gay E, Pasquier D, Grand S, Sindou M, Kopp 
N (2002) Chordoid glioma of the third ventricle: a report of two new 
cases, with further evidence supporting an ependymal differentiation, 
and review of the literature. Am J Surg Pathol 26(10):1330–1342
Prieto R, Pascual JM, Roda JM (2006) Third ventricle glioblastoma. Case 
report and review of literature. Clin Neurol Neurosurg 108(2):199–204. 
doi:10.1016/j.clineuro.2004.12.012
Schroeder HW (2013) Intraventricular tumors. World Neurosurg 79 (2 
Suppl.):S17 e15–S17e19. doi:10.1016/j.wneu.2012.02.023
Sheikh AB, Mendelson ZS, Liu JK (2014) Endoscopic versus microsurgi-
cal resection of colloid cysts: a systematic review and meta-analysis 
of 1,278 patients. World Neurosurg 82(6):1187–1197. doi:10.1016/j.
wneu.2014.06.024
Villani RM, Tomei G (2000) Transcallosal approach to tumours of the third 
ventricle. In: Sweet SA (ed) Schmidek & sweet operative neurosurgical 
techniques, indications, methods, and results, vol 1, 4th edn. Saunders, 
Philadelphia, pp 862–875
Vougiouklakis T, Mitselou A, Agnantis NJ (2006) Sudden death due to primary 
intracranial neoplasms. A forensic autopsy study. Anticancer Res 
26(3B):2463–2466
Yasargil MG (1996) Microneurosurgery of CNS tumors, chap 19, vol IV B. 
Thieme Medical, New York
